Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer

Completed · Phase 1/Phase 2

Conditions studied: Esophagus Cancer

In brief

In this phase I/II trial, we will evaluate a novel combination of chemotherapy, used concurrently with radiation therapy, in the preoperative therapy of locoregional carcinoma of the esophagus and gastroesophageal junction. In the brief phase I portion of this trial, we will determine whether 2 drugs (docetaxel/oxaliplatin) or 3 drugs (docetaxel/oxaliplatin/capecitabine) can be used concurrently with radiation therapy. If the 3-drug regimen is tolerated, the phase II portion will proceed with this regimen. If the 3-drug combination is considered too toxic, the phase II study will proceed with docetaxel/oxaliplatin in combination with radiation therapy.

Key facts

Study ID

NCT00193128

Run by

SCRI Development Innovations, LLC

People needed

59

Starts

2004-04-01

Expected to finish

2009-01-01

Last updated by the study team

2021-11-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• To be included in this study, you must meet the following criteria:
• Adenocarcinoma or squamous cell carcinoma of the esophagus or G/E junction.
• Must be surgical candidates
• No previous treatment for esophageal cancer
• Must have measurable or evaluable disease
• Able to perform activities of daily living with minimal to no assistance
• Adequate bone marrow, liver and kidney function
• Provide written informed consent

You may not qualify if…

• You cannot participate in this study if any of the following apply to you:
• Tumor location in the proximal esophagus
• Metastatic disease or locally advanced cancer
• Moderate to severe peripheral neuropathy
• Serious pre-existing medical illnesses
• Significant heart disease
• Treated for an invasive cancer within the previous 5 years
• Women who are pregnant or breast-feeding
• Age < 18 years
• Please note: There are additional inclusion/exclusion criteria. The study center will determine if you meet all of the criteria. If you do not qualify for the trial, study personnel will explain the reasons. If you do qualify, study personnel will explain the trial in detail and answer any questions you may have.

Where it is running

• Tower Oncology — Beverly Hills, California, United States
• Integrated Community Oncology Network — Jacksonville, Florida, United States
• Atlanta Cancer Care — Atlanta, Georgia, United States
• Northeast Georgia Medical Center — Gainesville, Georgia, United States
• Wellstar Cancer Research — Marietta, Georgia, United States
• Consultants in Blood Disorders and Cancer — Louisville, Kentucky, United States
• Tennessee Oncology — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.